Investment Thesis — Tenet Healthcare Corporation
The market underestimates Tenet's operating leverage from recent divestitures and its ability to drive margin expansion through ambulatory surgery centers (ASCs), not just hospitals. Investors are anchored to historical volatility and overlook the structural shift toward higher-margin outpatient care.
Catalysts
- Accelerated ASC volume growth and margin expansion
- Strategic divestitures or acquisitions that shift mix to outpatient
- Regulatory clarity favoring outpatient reimbursement
Risk Factors
- Regulatory changes reducing ASC reimbursement
- Labor shortages or wage inflation pressuring margins
- Slower-than-expected shift in payer or patient mix toward outpatient
Key Debates
THC's Fwd P/E re-rates to 15x by Q4 as selling subsides
THC's revenue growth exceeds 4.0% by H1 2025, boosting valuation
Short covering pushes THC above 220 by Q3 2024